MedPath

四川奇力制药有限公司

Ownership
-
Established
2001-09-24
Employees
-
Market Cap
-
Website
qilizhiyao.cn

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

90

NMPA:90

Drug Approvals

首乌延寿片

Approval Number
国药准字Z20055445
Approval Date
Nov 17, 2020
NMPA

Ethylenediamine Diaceturate and Sodium Chloride Injection

Product Name
邦林
Approval Number
国药准字H20050489
Approval Date
Nov 11, 2020
NMPA

Glucose and Sodium Chloride Injection

Product Name
葡萄糖氯化钠注射液
Approval Number
国药准字H20073171
Approval Date
Sep 30, 2020
NMPA

Glucose Injection

Product Name
葡萄糖注射液
Approval Number
国药准字H20073158
Approval Date
Sep 30, 2020
NMPA

Glucose and Sodium Chloride Injection

Product Name
葡萄糖氯化钠注射液
Approval Number
国药准字H51022465
Approval Date
Sep 30, 2020
NMPA

Glucose Injection

Product Name
葡萄糖注射液
Approval Number
国药准字H20073161
Approval Date
Sep 27, 2020
NMPA

Matrine and Glucose Injection

Product Name
青典
Approval Number
国药准字H20031102
Approval Date
Sep 27, 2020
NMPA

Compound Paracetamol and Chlorphenamine Tablets for Infant

Product Name
小儿氨酚那敏片
Approval Number
国药准字H51023733
Approval Date
Sep 27, 2020
NMPA

Glucose and Sodium Chloride Injection

Product Name
葡萄糖氯化钠注射液
Approval Number
国药准字H20073250
Approval Date
Sep 27, 2020
NMPA

Glucose Injection

Product Name
葡萄糖注射液
Approval Number
国药准字H20073159
Approval Date
Sep 27, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 9
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.